The interaction of ADAMTS-12 with fibulin-2 results in a blockade of the proteolytic degradation of fibulin-2 by ADAMTS4 and ADAMTS-5 and therefore, inhibition of the tumoral properties of breast cancer cells (Fontanil et al., 2017). Here, ADAMTS4 is linked to breast carcinoma.